AU5132590A – Method for silicon reduction with dimercaptosuccinic acid (dmsa)
– Google Patents
AU5132590A – Method for silicon reduction with dimercaptosuccinic acid (dmsa)
– Google Patents
Method for silicon reduction with dimercaptosuccinic acid (dmsa)
Info
Publication number
AU5132590A
AU5132590A
AU51325/90A
AU5132590A
AU5132590A
AU 5132590 A
AU5132590 A
AU 5132590A
AU 51325/90 A
AU51325/90 A
AU 51325/90A
AU 5132590 A
AU5132590 A
AU 5132590A
AU 5132590 A
AU5132590 A
AU 5132590A
Authority
AU
Australia
Prior art keywords
dmsa
dimercaptosuccinic acid
silicon
silicon reduction
preventing
Prior art date
1989-03-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU51325/90A
Other versions
AU626390B2
(en
Inventor
Harvey Craig Gonick
Farhad Khalil-Manesh
Elmar Willibald Johannes Weiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1989-03-17
Filing date
1990-03-14
Publication date
1990-11-08
1990-03-14
Application filed by Cedars Sinai Medical Center
filed
Critical
Cedars Sinai Medical Center
1990-11-08
Publication of AU5132590A
publication
Critical
patent/AU5132590A/en
1992-07-30
Application granted
granted
Critical
1992-07-30
Publication of AU626390B2
publication
Critical
patent/AU626390B2/en
2010-03-14
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K31/19—Carboxylic acids, e.g. valproic acid
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P13/00—Drugs for disorders of the urinary system
A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P15/00—Drugs for genital or sexual disorders; Contraceptives
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer’s disease or other forms of dementia
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P39/00—General protective or antinoxious agents
A61P39/02—Antidotes
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/12—Antihypertensives
Abstract
Dimercaptosuccinic Acid (DMSA) may be used to reduce the level of silicon in blood and tissue thereby reducing blood pressure, improving kidney function, preventing or retarding the progression of chronic renal failure, treating the accumulation of silicon in advanced kidney disease, and/or preventing the onset or improving the current status of dementia and Alzheimer’s Disease.
AU51325/90A
1989-03-17
1990-03-14
Method for silicon reduction with dimercaptosuccinic acid (dmsa)
Ceased
AU626390B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US325297
1989-03-17
US07/325,297
US4962127A
(en)
1989-03-17
1989-03-17
Method for silicon reduction with dimercaptosuccinic acid (DMSA)
Publications (2)
Publication Number
Publication Date
AU5132590A
true
AU5132590A
(en)
1990-11-08
AU626390B2
AU626390B2
(en)
1992-07-30
Family
ID=23267294
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU51325/90A
Ceased
AU626390B2
(en)
1989-03-17
1990-03-14
Method for silicon reduction with dimercaptosuccinic acid (dmsa)
Country Status (9)
Country
Link
US
(1)
US4962127A
(en)
EP
(1)
EP0388241B1
(en)
JP
(1)
JPH0729917B2
(en)
KR
(1)
KR920006904B1
(en)
AT
(1)
ATE117550T1
(en)
AU
(1)
AU626390B2
(en)
DE
(1)
DE69016232T2
(en)
IE
(1)
IE66237B1
(en)
PT
(1)
PT93462B
(en)
Families Citing this family (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5426122A
(en)
1989-03-17
1995-06-20
Cedars-Sinai Medical Center
Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA)
AU725537B2
(en)
*
1992-12-15
2000-10-12
Cedars-Sinai Medical Center
Methods for treatment with dimercaptosuccinic acid (DMSA)
US6664239B2
(en)
*
1997-05-06
2003-12-16
Vanderbilt University
Diagnosis and management of infection caused by Chlamydia
1989
1989-03-17
US
US07/325,297
patent/US4962127A/en
not_active
Expired – Fee Related
1990
1990-03-14
AU
AU51325/90A
patent/AU626390B2/en
not_active
Ceased
1990-03-16
PT
PT93462A
patent/PT93462B/en
active
IP Right Grant
1990-03-17
JP
JP2068003A
patent/JPH0729917B2/en
not_active
Expired – Lifetime
1990-03-17
KR
KR1019900003618A
patent/KR920006904B1/en
not_active
IP Right Cessation
1990-03-19
AT
AT90302905T
patent/ATE117550T1/en
not_active
IP Right Cessation
1990-03-19
EP
EP90302905A
patent/EP0388241B1/en
not_active
Expired – Lifetime
1990-03-19
DE
DE69016232T
patent/DE69016232T2/en
not_active
Expired – Fee Related
1990-03-20
IE
IE102190A
patent/IE66237B1/en
not_active
IP Right Cessation
Also Published As
Publication number
Publication date
KR900013956A
(en)
1990-10-22
ATE117550T1
(en)
1995-02-15
EP0388241A1
(en)
1990-09-19
JPH0729917B2
(en)
1995-04-05
PT93462B
(en)
1996-03-29
PT93462A
(en)
1990-11-07
KR920006904B1
(en)
1992-08-22
IE66237B1
(en)
1995-12-13
JPH037219A
(en)
1991-01-14
AU626390B2
(en)
1992-07-30
DE69016232D1
(en)
1995-03-09
US4962127A
(en)
1990-10-09
EP0388241B1
(en)
1995-01-25
IE901021L
(en)
1990-09-17
DE69016232T2
(en)
1995-05-24
Similar Documents
Publication
Publication Date
Title
AU6760987A
(en)
1987-07-16
Method of treating alzheimer's disease
GB9206861D0
(en)
1992-05-13
Wound healing and treatment of fibrotic disorders
EP0181732A3
(en)
1987-09-16
Automated photophoresis blood portion control methods and apparatus
AU7316591A
(en)
1991-09-18
Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
AU1820588A
(en)
1989-01-19
Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
DE3273611D1
(en)
1986-11-13
Infusion solutions for heart therapy
AU626390B2
(en)
1992-07-30
Method for silicon reduction with dimercaptosuccinic acid (dmsa)
CA2107914A1
(en)
1992-10-30
Method to profile and treat abnormal cells
CA2012470A1
(en)
1991-09-19
Method for silicon reduction with dimercaptosuccinic acid (dmsa)
AU569354B2
(en)
1988-01-28
(-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
CY2299B1
(en)
2003-07-04
Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema
EP0116628A4
(en)
1985-02-18
1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents.
AU573448B2
(en)
1988-06-09
Method of treating geriatric disorders with terguride
GB2197199B
(en)
1991-04-03
Medicament for treatment of pregnancy-induced hypertension.
EP0192327A3
(en)
1989-07-19
Use of phosphonoformic acid and its esters and salts for the manufacture of a medicament for the treatment of AIDS
Ellison et al.
1983
Penetration of I super (125) labelled N. nigricollis venom in relationship to effects on the corneal erosion syndrome in albino and pigmented rabbits.
Carroll
1987
Contouring of a Solid Silicone Block: A New Use for the Shaw Scalpel. By IT Jackson and SJ Krall. Plast Reconst Surg 1986; 78, 528-9.
Ponzio et al.
1986
Topical application of hyaluronic acid in the treatment of skin ulcers.
AU1162788A
(en)
1988-08-18
Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
EP0173480A3
(en)
1987-09-16
The antiviral use of phyllanthostatins
Kobus
1983
Face: The surgical treatment of vascular tumours of the face.
ZA844114B
(en)
1986-01-29
6(or 5)-hydroxybenzothiazole-2-sulfonamide-o-sulfate salts for the topical treatment of elevated intraocular pressure
Berra et al.
1984
MODIFICATIONS OF PLASMA MEMBRANE COMPONENTS DURING BRAIN DEVELOPMENT INDUCED BY DIETARY TREATMENTS.
Beheri
1983
Protein requirements in patients having chronic septic deep burn wounds.
Hannedouche et al.
1986
Ketanserin and Nifedipine in the Treatment of Arterial Hypertension in Patients Over 50 Years Old. Preliminary Results of an International Trial.
Legal Events
Date
Code
Title
Description
2000-10-19
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
